Pasquale Abete Selected Research

Pasquale Abete Research Topics

Disease

7	Sarcopenia 11/2021 - 01/2015
6	Frailty 04/2022 - 01/2018
6	COVID-19 01/2022 - 01/2021
6	Heart Failure 01/2020 - 01/2015
5	Neoplasms (Cancer) 01/2021 - 06/2011
5	Myocardial Ischemia (Ischemic Heart Diseases) 01/2015 - 12/2002
4	Orthostatic Hypotension (Postural Hypotension) 12/2024 - 07/2013
4	Myocardial Infarction 01/2022 - 07/2006
4	Ischemia 07/2019 - 09/2004
3	Infarction (Infarctions) 01/2022 - 02/2002
3	Stroke (Strokes) 06/2021 - 06/2011
3	Ischemic Stroke 06/2021 - 06/2013
3	Inflammation (Inflammations) 06/2021 - 09/2019
3	Cardiotoxicity 11/2019 - 01/2015
3	Hypertension (High Blood Pressure) 01/2015 - 01/2014
3	Coronary Artery Disease (Coronary Atherosclerosis) 11/2007 - 12/2002
2	Atherosclerosis 01/2022 - 12/2014
2	Atrial Fibrillation 06/2021 - 01/2019
2	Thrombosis (Thrombus) 05/2020 - 06/2011
2	Syncope (Fainting) 01/2020 - 01/2018
2	Dementia (Dementias) 01/2020 - 01/2018
2	Wounds and Injuries (Trauma) 01/2016 - 06/2008
1	Chronic Renal Insufficiency 12/2024
1	Chest Pain (Chest Pains) 01/2022
1	Infections 01/2022
1	Anemia 11/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Right Ventricular Dysfunction 06/2020
1	Pulmonary Arterial Hypertension 06/2020
1	Systemic Scleroderma (Systemic Sclerosis) 06/2020
1	Pulmonary Hypertension 06/2020
1	Necrosis 05/2020
1	Muscular Atrophy (Muscle Atrophy) 04/2020
1	Endocarditis 01/2020
1	Obesity 01/2020
1	Lymphoma (Lymphomas) 11/2019
1	Fibrosis (Cirrhosis) 11/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2019
1	Type 2 Diabetes Mellitus (MODY) 09/2019
1	Alzheimer Disease (Alzheimer's Disease) 07/2019
1	Cognitive Dysfunction 07/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2019
1	Brain Ischemia (Cerebral Ischemia) 07/2019

Drug/Important Bio-Agent (IBA)

4	hydroxide ionIBA 12/2024 - 07/2013
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2015
3	Phosphotransferases (Kinase)IBA 01/2022 - 01/2016
3	NitratesIBA 01/2018 - 12/2002
2	CreatinineIBA 01/2022 - 02/2014
2	Proteins (Proteins, Gene)FDA Link 04/2020 - 01/2020
2	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2020 - 01/2020
2	Antineoplastic Agents (Antineoplastics)IBA 11/2019 - 01/2015
2	HLA Antigens (Human Leukocyte Antigens)IBA 02/2014 - 08/2013
2	Losartan (Cozaar)FDA LinkGeneric 11/2007 - 09/2004
2	Angiotensin Receptor AntagonistsIBA 11/2007 - 09/2004
2	Nitroglycerin (Dynamite)FDA LinkGeneric 09/2004 - 12/2002
1	Prothrombin (Factor II)IBA 01/2022
1	CytokinesIBA 01/2022
1	CholesterolIBA 01/2022
1	LectinsIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	AlarminsIBA 01/2022
1	PolyphenolsIBA 06/2021
1	phenolic acidIBA 06/2021
1	MicronutrientsIBA 06/2021
1	FlavonolsIBA 06/2021
1	SirtuinsIBA 06/2021
1	S- (2- chloro- 1,1,2- trifluoroethyl)cysteine (CTFC)IBA 05/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	AldosteroneIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Heparin (Liquaemin)FDA LinkGeneric 01/2021
1	Vasodilator Agents (Vasodilators)IBA 06/2020
1	Oxygen (Dioxygen)IBA 05/2020
1	GlucocorticoidsIBA 01/2020
1	4-hydroxyphenylethanolIBA 01/2020
1	Memantine (Namenda)FDA Link 01/2020
1	AnthracyclinesIBA 11/2019
1	Glucose (Dextrose)FDA LinkGeneric 09/2019
1	Insulin (Novolin)FDA Link 09/2019
1	Sirtuin 1IBA 09/2019
1	Protein Kinases (Protein Kinase)IBA 07/2019
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 07/2019
1	Butyric Acid (Butanoic Acid)IBA 01/2019
1	Volatile Fatty AcidsIBA 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019

Therapy/Procedure

8	Therapeutics 06/2020 - 12/2002
3	Activities of Daily Living (ADL) 11/2021 - 10/2004
2	Cardiac Rehabilitation 01/2019 - 07/2006
2	Bed Rest (Bedrest) 01/2019 - 12/2017
1	Noninvasive Ventilation 04/2022
1	Personal Protective Equipment 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021
1	Heart Transplantation (Grafting, Heart) 01/2020
1	Transcatheter Aortic Valve Replacement 01/2020
1	Radiotherapy 11/2019
1	Drug Therapy (Chemotherapy) 11/2019
1	Aftercare (After-Treatment) 11/2019
1	Polypharmacy 04/2019